MedPAC Wants To Boost Generic Use By Low-Income Part D Enrollees Via Lower Copays
This article was originally published in The Pink Sheet Daily
Executive Summary
At its December meeting, the Medicare Payment Advisory Commission recommends that Congress increase the difference between copayments for generic and branded drugs used by low-income beneficiaries to encourage greater generic use in that population.